Inspra (eplerenone)

pCPA File Number: 20835
Negotiation Status:
Concluded with an LOI
Indication(s):
Post myocardial infarction
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
SR0342-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: